Posted by Dr. Bob on March 19, 2001, at 23:47:47
In reply to tx resistant clinical trial, posted by sarai on March 19, 2001, at 14:07:08
> Regarding a clinical trial I posted about the other day:
>
> The prinicipal investigator is Dr. David Hellerstein, and the study is being conducted
> at Beth Israel and was approved by their Institutional Review Board. The study will
> also be expanded to St. Luke's Roosevelt Hospital Center in NYC in the next month
> or two, after approval by the IRB.Fantastic, thanks for following up on that, and feel free to repost this to the main board. But maybe include what it is that's supposed to be tx resistant? :-)
Bob
poster:Dr. Bob
thread:848
URL: http://www.dr-bob.org/babble/admin/20010315/msgs/849.html